These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11960332)

  • 21. Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseases.
    Roberts MM; Dyson PG; Willson K; Juttner CA; To LB
    Bone Marrow Transplant; 1996 Jul; 18(1):41-5. PubMed ID: 8831994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the unfolded protein response in human acute myeloid leukemia.
    Schardt JA; Mueller BU; Pabst T
    Methods Enzymol; 2011; 489():227-43. PubMed ID: 21266233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying leukemia stem cells--is it feasible and does it matter?
    Lutz C; Hoang VT; Buss E; Ho AD
    Cancer Lett; 2013 Sep; 338(1):10-4. PubMed ID: 22820159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.
    Drummond MW; Balabanov S; Holyoake TL; Brummendorf TH
    Stem Cells; 2007 Aug; 25(8):1853-61. PubMed ID: 17510216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human leukaemic stem cells: a novel target of therapy.
    Sperr WR; Hauswirth AW; Florian S; Ohler L; Geissler K; Valent P
    Eur J Clin Invest; 2004 Aug; 34 Suppl 2():31-40. PubMed ID: 15291804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic implications of leukemia stem cell development.
    Stubbs MC; Armstrong SA
    Clin Cancer Res; 2007 Jun; 13(12):3439-42. PubMed ID: 17575205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
    Hoang VT; Zepeda-Moreno A; Ho AD
    Biotechnol J; 2012 Jun; 7(6):779-88. PubMed ID: 22588704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential.
    Cheung AM; Wan TS; Leung JC; Chan LY; Huang H; Kwong YL; Liang R; Leung AY
    Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia.
    Ye M; Zhang H; Yang H; Koche R; Staber PB; Cusan M; Levantini E; Welner RS; Bach CS; Zhang J; Krivtsov AV; Armstrong SA; Tenen DG
    Cell Stem Cell; 2015 Nov; 17(5):611-23. PubMed ID: 26412561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and analysis of normal and leukemic stem cells: current concepts and future directions.
    Brendel C; Neubauer A
    Leukemia; 2000 Oct; 14(10):1711-7. PubMed ID: 11021745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolutionarily conserved signaling pathways: acting in the shadows of acute myelogenous leukemia's genetic diversity.
    Heidel FH; Arreba-Tutusaus P; Armstrong SA; Fischer T
    Clin Cancer Res; 2015 Jan; 21(2):240-8. PubMed ID: 25593343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular targeted therapy for leukemic stem cells].
    Kikushige Y
    Nihon Rinsho; 2015 May; 73(5):811-5. PubMed ID: 25985636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute myeloid leukemia stem cells from genomic and immunological perspectives].
    Goyama S
    Rinsho Ketsueki; 2020; 61(9):1130-1137. PubMed ID: 33162508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia.
    Saha S; Murmu KC; Biswas M; Chakraborty S; Basu J; Madhulika S; Kolapalli SP; Chauhan S; Sengupta A; Prasad P
    Front Oncol; 2019; 9():692. PubMed ID: 31448224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic Abnormalities in Acute Myeloid Leukemia and Leukemia Stem Cells.
    Xu J; Hang X; Wu B; Chen C; Liu Y
    Adv Exp Med Biol; 2019; 1143():173-189. PubMed ID: 31338820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukemic stem cells show the way.
    Bonnet D
    Folia Histochem Cytobiol; 2005; 43(4):183-6. PubMed ID: 16382881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myelogenous leukemia stem cells: from Bench to Bedside.
    Felipe Rico J; Hassane DC; Guzman ML
    Cancer Lett; 2013 Sep; 338(1):4-9. PubMed ID: 22713929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.